Pharmacology News

In a large network meta-analysis of pharmacological, psychological and neurostimulatory ADHD interventions, only stimulants and atomoxetine were associated with short-term reductions in core symptoms among adults.

In three clinical trials, treatment with atogepant relieved migraine symptoms as soon as day 1, with consistent reductions through 4 weeks compared with placebo, according to research published in Neurology.

Antibiotic use was not associated with incident dementia, cognitive impairment with no dementia or accelerated cognitive decline among a large cohort of healthy Australian older adults, according to a post-hoc analysis of the ASPREE trial.

Updated guidelines from the American Psychiatric Association highlight psychotherapy as “the core of treatment” for borderline personality disorder in adolescents and adults.

SAN ANTONIO — Tirzepatide confers significant weight loss and cardiometabolic benefits for patients with diabetes and overweight or obesity, especially for those who lose more weight earlier during treatment, a speaker reported.

Researchers found that removing Clostridioides difficile from gastrointestinal pathogen panels reduced unnecessary treatment without causing delays in diagnosis.

Syphilis, an STI caused by the bacterium Treponema pallidum, has re-emerged as a major public health threat in the United States, with rates skyrocketing over the past decade.

Researchers found that patients who participated in an obesity management program and were taking weight-loss medication reported drinking less alcohol.

Treating patients with bone and joint infections with oral antibiotics led to more patients being discharged exclusively on oral antibiotics and shorter hospital stays without increasing rates of treatment failure, researchers found in a study.